Georgia Hatzivassiliou
118 works · 14,673 citations · h-index 33
Top works
- The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
- RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
- ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation
- ATP citrate lyase inhibition can suppress tumor cell growth
- The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid β-oxidation
- Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis
- ATP citrate lyase is an important component of cell growth and transformation
- IRTA1 and IRTA2, Novel Immunoglobulin Superfamily Receptors Expressed in B Cells and Involved in Chromosome 1q21 Abnormalities in B Cell Malignancy
- Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers
- PERK-dependent regulation of lipogenesis during mouse mammary gland development and adipocyte differentiation
- ERK Inhibition Overcomes Acquired Resistance to MEK Inhibitors
- Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors
- Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2
- Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT)
- IRTAs: a new family of immunoglobulinlike receptors differentially expressed in B cells
- Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition
- An Integrated Genomic Screen Identifies LDHB as an Essential Gene for Triple-Negative Breast Cancer
- mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells
- p53 mutations in bladder carcinoma cell lines.
- NRF2 Activation Promotes Aggressive Lung Cancer and Associates with Poor Clinical Outcomes